bpc-157 human clinical trials randomized controlled Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation | Journal of Molecular Medicine Wellness clinics promote the use
Description
Kubiniok, B
The hydrogel dressing comprised PVA, a ROS-responsive linker EBPBA, and dimeric copper peptide D-CuP
This supports laboratories that need one stable reference point to cite in internal paperwork, method templates, and controlled documentation
Benefits outlined on AgelessRx.com are based on 3rd party studies
However: No large, peer-reviewed human trials exist demonstrating proven benefit
(2018) 7:e1458809
